J&J projects 5-6% revenue growth in 2024, fueled by strong core businesses, acquisitions, and a robust pipeline targeting $57 billion in drug sales by 2025.
![Johnson & Johnson’s prescription for growth](https://thelosangelesentrepreneur.com/wp-content/uploads/2023/12/hero-image-marketbeat-466464-6R2H8v-1024x637.jpeg)
J&J projects 5-6% revenue growth in 2024, fueled by strong core businesses, acquisitions, and a robust pipeline targeting $57 billion in drug sales by 2025.